TLR4 and bacterial infectious disease: These findings help to resolve an understanding of biased TLR4 signalling in response to LPS and opens up new avenues for TLR4 as a therapeutic intervention strategy during bacterial infection and also chronic inflammation during microbial dysbiosis.